In summary, we found that cisplatin-selected resistance (oncogenic resistance) transactivates STAT3/Snail pathway, and the axis regulates tumor migration/invasion, cancer stem-like cell properties, and cisplatin resistance in ATRT cells (Figure 8D). This evidence concerns the gene SNAI1 and neoplasm.